Global connected drug delivery devices market is expected to grow at an impressive CAGR in the forecast years. The market showed a consistent growth in the historical years from 2016-2019, on account of superior patient supervision requirement and counselling, the market is anticipated to grow in the forecast period, 2022-2026. Moreover, uses of electronic technology in healthcare devices coupled with drug delivery devices’ efficiency the market is projected to grow at an exponential growth in the upcoming five years.

The global connected drug delivery devices market is segmented by product type, technology, application, end user, and regional distribution. Based on product type the market is further fragmented into connected sensors, and integrated connected devices. Connected sensors have convenient integration with the existing delivery devices and thus it dominates the market and is anticipated to dominate the drug delivery devices market in next five years too. Connected sensors do not interfere with working of delivery devices and is reusable even if the delivery device is disposed. Moreover, increasing cases of chronic respiratory diseases, chronic obtrusive pulmonary disease is expected to boost the integrated connected drug delivery devices market in the future too.

Some of the major competitors in the market are Abbott Laboratories, Inc., Reciprocal Labs Corporation (Propeller Health), F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Biocorp Production SA, Merck KGaA, Adherium Ltd, West Pharmaceutical Services, Inc., Aterica Digital Health, Molex LLC (Phillips Medisize), Cohero Health, Inc., Elcam Medical ACS. Ltd, Becton, Dickinson, and Company, Ypsomed Holding AG, Unilife Corporation, among others. The companies are focusing on extensive research and developments activities to stay competitive in the market. Other competitive strategies include formation of alliances and partnerships.

Years considered for this report:

Historical Years: 2016 – 2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022 – 2026

Objective of the Study:

  • To analyze and forecast the market size of Global connected drug delivery devices market from 2016 to 2019.
  • To estimate and forecast the market size of Global connected drug delivery devices market from 2020 to 2026 and growth rate until 2026. 
  • To classify and forecast Global connected drug delivery devices market based on product type, technology, application, end user, and regional distribution.
  • To identify dominant region or segment in the Global connected drug delivery devices market.
  • To identify drivers and challenges for Global connected drug delivery devices market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in Global connected drug delivery devices market.
  • To identify and analyze the profile of leading players operating in Global connected drug delivery devices market.
  • To identify key sustainable strategies adopted by market players in Global connected drug delivery devices market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and service providers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of Global connected drug delivery devices market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analysing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Connected drug delivery devices manufacturers, end users, service providers and other stakeholders
  • Distributers and suppliers of connected drug delivery devices and services and other stakeholders
  • Organizations, forums, and alliances related to connected drug delivery devices   
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, Global connected drug delivery devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Product Type:
    • Connected Sensors
    • Integrated Connected Devices
  • Market, By Technology:
    • Bluetooth
    • Near Field Communications
    • Others
  • Market, By Application:

o   Asthma & COPD

o   Diabetes

o   Others

  • Market, By End User:

o   Healthcare Providers

o   Home Care

  • Market, By Region:
    • North America
    • APAC
    • Europe
    • MEA
    • South America

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global connected drug delivery devices market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global Connected Drug Delivery Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

1.     Product Overview

2.     Research Methodology

3.     Impact of COVID-19 on Global Connected Drug Delivery Devices Market

4.     Voice of Customer

5.     Executive Summary

6.     Global Connected Drug Delivery Devices Market Outlook

6.1.   Market Size & Forecast

6.1.1.      By Value

6.2.   Market Share & Forecast

6.2.1.      By Product Type (Connected Sensors v/s Integrated Connected Devices)

6.2.2.      By Technology (Bluetooth, Near Field Communication, Others)

6.2.3.      By Application (Asthma & COPD, Diabetes, Others)

6.2.4.      By End User (Healthcare Providers v/s Homecare)

6.2.5.      By Company (2019)

6.2.6.      By Region

6.3.   Product Market Map

7.     Asia-Pacific Connected Drug Delivery Devices Market Outlook

7.1.   Market Size & Forecast          

7.1.1.      By Value

7.2.   Market Share & Forecast

7.2.1.      By Product Type

7.2.2.      By Technology

7.2.3.      By Application

7.2.4.      By End User

7.2.5.      By Country

7.3.   Asia-Pacific: Country Analysis

7.3.1.      China Connected Drug Delivery Devices Market Outlook

7.3.1.1.           Market Size & Forecast

7.3.1.1.1.                By Value

7.3.1.2.           Market Share & Forecast

7.3.1.2.1.                By Product Type

7.3.1.2.2.                By Technology

7.3.1.2.3.                By Application

7.3.1.2.4.                By End User

7.3.2.      India Connected Drug Delivery Devices Market Outlook

7.3.2.1.           Market Size & Forecast

7.3.2.1.1.                By Value

7.3.2.2.           Market Share & Forecast

7.3.2.2.1.                By Product Type

7.3.2.2.2.                By Technology

7.3.2.2.3.                By Application

7.3.2.2.4.                By End User

7.3.3.      South Korea Connected Drug Delivery Devices Market Outlook

7.3.3.1.           Market Size & Forecast

7.3.3.1.1.                By Value

7.3.3.2.           Market Share & Forecast

7.3.3.2.1.                By Product Type

7.3.3.2.2.                By Technology

7.3.3.2.3.                By Application

7.3.3.2.4.                By End User

7.3.4.      Japan Connected Drug Delivery Devices Market Outlook

7.3.4.1.           Market Size & Forecast

7.3.4.1.1.                By Value

7.3.4.2.           Market Share & Forecast

7.3.4.2.1.                By Product Type

7.3.4.2.2.                By Technology

7.3.4.2.3.                By Application

7.3.4.2.4.                By End User

7.3.5.      Australia Connected Drug Delivery Devices Market Outlook

7.3.5.1.           Market Size & Forecast

7.3.5.1.1.                By Value

7.3.5.2.           Market Share & Forecast

7.3.5.2.1.                By Product Type

7.3.5.2.2.                By Technology

7.3.5.2.3.                By Application

7.3.5.2.4.                By End User

8.     Europe Connected Drug Delivery Devices Market Outlook

8.1.   Market Size & Forecast          

8.1.1.      By Value

8.2.   Market Share & Forecast

8.2.1.      By Product Type

8.2.2.      By Technology

8.2.3.      By Application

8.2.4.      By End User

8.2.5.      By Country

8.3.   Europe: Country Analysis

8.3.1.      France Connected Drug Delivery Devices Market Outlook

8.3.1.1.           Market Size & Forecast

8.3.1.1.1.                By Value

8.3.1.2.           Market Share & Forecast

8.3.1.2.1.                By Product Type

8.3.1.2.2.                By Technology

8.3.1.2.3.                By Application

8.3.1.2.4.                By End User

8.3.2.      Germany Connected Drug Delivery Devices Market Outlook

8.3.2.1.           Market Size & Forecast

8.3.2.1.1.                By Value

8.3.2.2.           Market Share & Forecast

8.3.2.2.1.                By Product Type

8.3.2.2.2.                By Technology

8.3.2.2.3.                By Application

8.3.2.2.4.                By End User

8.3.3.      United Kingdom Connected Drug Delivery Devices Market Outlook

8.3.3.1.           Market Size & Forecast

8.3.3.1.1.                By Value

8.3.3.2.           Market Share & Forecast

8.3.3.2.1.                By Product Type

8.3.3.2.2.                By Technology

8.3.3.2.3.                By Application

8.3.3.2.4.                By End User

8.3.4.      Italy Connected Drug Delivery Devices Market Outlook

8.3.4.1.           Market Size & Forecast

8.3.4.1.1.                By Value

8.3.4.2.           Market Share & Forecast

8.3.4.2.1.                By Product Type

8.3.4.2.2.                By Technology

8.3.4.2.3.                By Application

8.3.4.2.4.                By End User

8.3.5.      Spain Connected Drug Delivery Devices Market Outlook

8.3.5.1.           Market Size & Forecast

8.3.5.1.1.                By Value

8.3.5.2.           Market Share & Forecast

8.3.5.2.1.                By Product Type

8.3.5.2.2.                By Technology

8.3.5.2.3.                By Application

8.3.5.2.4.                By End User

9.     North America Connected Drug Delivery Devices Market Outlook

9.1.   Market Size & Forecast          

9.1.1.      By Value

9.2.   Market Share & Forecast

9.2.1.      By Product Type

9.2.2.      By Technology

9.2.3.      By Application

9.2.4.      By End User

9.2.5.      By Country

9.3.   North America: Country Analysis

9.3.1.      United States Connected Drug Delivery Devices Market Outlook

9.3.1.1.           Market Size & Forecast

9.3.1.1.1.                By Value

9.3.1.2.           Market Share & Forecast

9.3.1.2.1.                By Product Type

9.3.1.2.2.                By Technology

9.3.1.2.3.                By Application

9.3.1.2.4.                By End User

9.3.2.      Mexico Connected Drug Delivery Devices Market Outlook

9.3.2.1.           Market Size & Forecast

9.3.2.1.1.                By Value

9.3.2.2.           Market Share & Forecast

9.3.2.2.1.                By Product Type

9.3.2.2.2.                By Technology

9.3.2.2.3.                By Application

9.3.2.2.4.                By End User

9.3.3.      Canada Connected Drug Delivery Devices Market Outlook

9.3.3.1.           Market Size & Forecast

9.3.3.1.1.                By Value

9.3.3.2.           Market Share & Forecast

9.3.3.2.1.                By Product Type

9.3.3.2.2.                By Technology

9.3.3.2.3.                By Application

9.3.3.2.4.                By End User

10.  South America Connected Drug Delivery Devices Market Outlook

10.1.                 Market Size & Forecast

10.1.1.   By Value

10.2.                 Market Share & Forecast

10.2.1.   By Product Type

10.2.2.   By Technology

10.2.3.   By Application

10.2.4.   By End User

10.2.5.   By Country

10.3.                 South America: Country Analysis

10.3.1.   Brazil Connected Drug Delivery Devices Market Outlook

10.3.1.1.        Market Size & Forecast

10.3.1.1.1.             By Value

10.3.1.2.        Market Share & Forecast

10.3.1.2.1.             By Product Type

10.3.1.2.2.             By Technology

10.3.1.2.3.             By Application

10.3.1.2.4.             By End User

10.3.2.   Argentina Connected Drug Delivery Devices Market Outlook

10.3.2.1.        Market Size & Forecast

10.3.2.1.1.             By Value

10.3.2.2.        Market Share & Forecast

10.3.2.2.1.             By Product Type

10.3.2.2.2.             By Technology

10.3.2.2.3.             By Application

10.3.2.2.4.             By End User

10.3.3.   Colombia Connected Drug Delivery Devices Market Outlook

10.3.3.1.        Market Size & Forecast

10.3.3.1.1.             By Value

10.3.3.2.        Market Share & Forecast

10.3.3.2.1.             By Product Type

10.3.3.2.2.             By Technology

10.3.3.2.3.             By Application

10.3.3.2.4.             By End User

11.  Middle East and Africa Connected Drug Delivery Devices Market Outlook

11.1.                 Market Size & Forecast

11.1.1.   By Value

11.2.                 Market Share & Forecast

11.2.1.   By Product Type

11.2.2.   By Technology

11.2.3.   By Application

11.2.4.   By End User

11.2.5.   By Country

11.3.                 MEA: Country Analysis

11.3.1.   South Africa Connected Drug Delivery Devices Market Outlook

11.3.1.1.        Market Size & Forecast

11.3.1.1.1.             By Value

11.3.1.2.        Market Share & Forecast

11.3.1.2.1.             By Product Type

11.3.1.2.2.             By Technology

11.3.1.2.3.             By Application

11.3.1.2.4.             By End User

11.3.2.   Saudi Arabia Connected Drug Delivery Devices Market Outlook

11.3.2.1.        Market Size & Forecast

11.3.2.1.1.             By Value

11.3.2.2.        Market Share & Forecast

11.3.2.2.1.             By Product Type

11.3.2.2.2.             By Technology

11.3.2.2.3.             By Application

11.3.2.2.4.             By End User

11.3.3.   UAE Connected Drug Delivery Devices Market Outlook

11.3.3.1.        Market Size & Forecast

11.3.3.1.1.             By Value

11.3.3.2.        Market Share & Forecast

11.3.3.2.1.             By Product Type

11.3.3.2.2.             By Technology

11.3.3.2.3.             By Application

11.3.3.2.4.             By End User

11.3.4.   Kuwait Connected Drug Delivery Devices Market Outlook

11.3.4.1.        Market Size & Forecast

11.3.4.1.1.             By Value

11.3.4.2.        Market Share & Forecast

11.3.4.2.1.             By Product Type

11.3.4.2.2.             By Technology

11.3.4.2.3.             By Application

11.3.4.2.4.             By End User

12.  Market Dynamics

12.1.                 Drivers

12.2.                 Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.                 Abbott Laboratories, Inc.

14.2.                 Reciprocal Labs Corporation (Propeller Health)

14.3.                 F. Hoffmann-La Roche Ltd.

14.4.                 Teva Pharmaceutical Industries Ltd.

14.5.                 Biocorp Production SA

14.6.                 Merck KGaA

14.7.                 Adherium Ltd

14.8.                 West Pharmaceutical Services, Inc.

14.9.                 Aterica Digital Health

14.10.              Molex LLC (Phillips Medisize)

14.11.              Cohero Health, Inc.

14.12.              Elcam Medical ACS. Ltd

14.13.              Becton, Dickinson, and Company

14.14.              Ypsomed Holding AG

14.15.              Unilife Corporation

15.  Strategic Recommendations

16.  About Us & Disclaimer